The Research and Development team at AnaptysBio focuses on the discovery and optimization of therapeutic antibodies aimed at addressing unmet needs in inflammation. They conduct cutting-edge research in antibody development, formulate drug products, and manage clinical development processes, all while ensuring rigorous bioanalytical and protein sciences support. By leveraging a diverse mix of expertise, this team drives the advancement of innovative antibody candidates from early-stage development through clinical trials.
View all